FDA to reconsider treatment for rare cancer after its surprise rejection - statnews.com
Source:STAT
The companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.
Related Articles
Some iPhone owners could get up to $95 payment after Apple agrees to settle case for $250 million - AP News
Apple has agreed to a $250 million settlement in a class-action lawsuit over false advertising of …
US Bonds Fall as Strong Jobs Data Undermines Fed Cut Outlook - Bloomberg.com
Treasuries fell as a solid reading of the US labor market prompted traders to reduce bets the …
Amazon orders 90-day reset after code mishaps cause millions of lost orders - Business Insider
Internal documents obtained by Business Insider show how Amazon is reacting to a series of recent …
Fed Seeks Details on US Banks’ Exposure to Private Credit Firms - Bloomberg.com
The Federal Reserve is asking major US banks for details about their exposure to private credit …